» Articles » PMID: 28709161

Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV

Abstract

Background: Medication adherence is a critical but challenging developmental task for children and adolescents with perinatally acquired HIV (PHIV). Understanding how medication responsibility, executive functions (EFs) and adaptive functioning (AF) influence adherence may help prepare adolescents for transition to adulthood.

Methods: Participants included PHIV children and adolescents 7-16 years of age enrolled in the Pediatric HIV/AIDS Cohort Study Adolescent Master Protocol, who were prescribed antiretroviral medications. Measures included caregiver report and child self-report measures of adherence, medication responsibility and EF, caregiver report of child AF, examiner-administered tests of EF and processing speed and demographic and health characteristics.

Results: Two hundred fifty-six participants with PHIV (mean age: 12 years old) were 51% female, 80% black and 79% non-Hispanic. Per 7-day recall, 72% were adherent (no missed doses). Children/adolescents self-reported that 22% had sole and 55% had shared medication responsibility. Adjusted logistic models revealed significantly higher odds of adherence with sole caregiver responsibility for medication [odds ratio (OR): 4.10, confidence interval (CI): 1.43-11.8, P = 0.009], child nadir CD4% <15% (OR: 2.26, CI: 1.15-4.43, P = 0.018), better self-reported behavioral regulation (OR: 0.65, CI: 0.44-0.96, P = 0.029) and slower processing speed (OR: 0.54, CI: 0.38-0.77, P < 0.001), adjusting for demographic variables (age, race and caregiver education).

Conclusions: Among children and adolescents with PHIV, continued caregiver medication management, especially during adolescence, is essential. Although global EF and AF were not significantly associated with adherence, behavioral regulation was. Given that EF and AF develop throughout adolescence, their relationships to adherence should be evaluated longitudinally, especially as youth transition to adulthood and caregiver responsibility diminishes.

Citing Articles

AI applications in HIV research: advances and future directions.

Jin R, Zhang L Front Microbiol. 2025; 16:1541942.

PMID: 40051479 PMC: 11882587. DOI: 10.3389/fmicb.2025.1541942.


Mixed Methods Evaluation of a Youth-Friendly Clinic for Young People Living with HIV Transitioning from Pediatric Care.

Chew H, Bonnet K, Schlundt D, Hill N, Pierce L, Ahonkhai A Trop Med Infect Dis. 2024; 9(9).

PMID: 39330887 PMC: 11435583. DOI: 10.3390/tropicalmed9090198.


Factors Impacting the Treatment Readiness of Youth Starting Antiretroviral Treatment in the United States.

Hall A, Naar S, Outlaw A, Templin T, Green Jones M, MacDonell K AIDS Patient Care STDS. 2024; 38(6):249-251.

PMID: 38742985 PMC: 11301701. DOI: 10.1089/apc.2024.0072.


Central Nervous System Complications of HIV in Children.

Huff H, Sportiello K, Bearden D Curr HIV/AIDS Rep. 2024; 21(2):40-51.

PMID: 38252368 DOI: 10.1007/s11904-024-00689-x.


"I can live a normal life": Exploring adherence to antiretroviral therapy in Indonesian adolescents living with HIV.

Nuraidah , Wanda D, Hayati H, Rachmawati I, Waluyo A Belitung Nurs J. 2023; 8(2):108-114.

PMID: 37521893 PMC: 10386811. DOI: 10.33546/bnj.2024.


References
1.
Simoni J, Montgomery A, Martin E, New M, Demas P, Rana S . Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007; 119(6):e1371-83. PMC: 5096441. DOI: 10.1542/peds.2006-1232. View

2.
Usitalo A, Leister E, Tassiopoulos K, Allison S, Malee K, Paul M . Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection. AIDS Care. 2013; 26(1):107-15. PMC: 4190051. DOI: 10.1080/09540121.2013.802280. View

3.
Wysocki T, Nansel T, Holmbeck G, Chen R, Laffel L, Anderson B . Collaborative involvement of primary and secondary caregivers: associations with youths' diabetes outcomes. J Pediatr Psychol. 2008; 34(8):869-81. PMC: 2729681. DOI: 10.1093/jpepsy/jsn136. View

4.
Van Dyke R, Lee S, Johnson G, Wiznia A, Mohan K, Stanley K . Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002; 109(4):e61. DOI: 10.1542/peds.109.4.e61. View

5.
Ettenhofer M, Foley J, Castellon S, Hinkin C . Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology. 2010; 74(15):1217-22. PMC: 2865732. DOI: 10.1212/WNL.0b013e3181d8c1ca. View